Ignite Creation Date:
2024-05-06 @ 12:58 PM
Last Modification Date:
2024-10-26 @ 1:06 PM
Study NCT ID:
NCT03892525
Status:
TERMINATED
Last Update Posted:
2021-07-26
First Post:
2019-03-26
Brief Title:
Study of Intratumoral Selicrelumab With Atezolizumab in Patients With Refractory or Relapsed B Cell Lymphoma
Sponsor:
The Lymphoma Academic Research Organisation
Organization:
The Lymphoma Academic Research Organisation
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-07-04
Start Date Type:
ACTUAL
Primary Completion Date:
2021-04-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-04-07
Completion Date Type:
ACTUAL
First Submit Date:
2019-03-26
First Submit QC Date:
March 26 2019
Study First Post Date:
2019-03-27
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-07-23
Last Update Post Date:
2021-07-26
Last Update Post Date Type:
ACTUAL